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Dek: A tyrosine-targeting bioconjugation reaction leads to a Cas9 protein-peptide conjugate 
that displays a 20-fold increase in cellular delivery. 
 
https://pubs.acs.org/doi/10.1021/acscentsci.0c00940 links to “tyrosine-targeting 
bioconjugation reaction” 
 
 
The residues cysteine and lysine are the undisputed champions of bioconjugation chemistry. 
Targeting other amino acids has been touted as a potential way to improve the synthesis of 
protein-peptide and protein-protein conjugates that are widely studied for their potential 
therapeutic ability and used as tools for understanding biological function. Now, a team of 
researchers at the University of California, Berkeley, have targeted solvent-exposed tyrosine 
residues to develop a method of preparing such conjugates.1 
 
The synthesis of protein-peptide and protein-protein conjugates can be tricky due to the 
diverse chemical functionality in proteins posing chemoselectivity and site-specificity 
challenges.2 The use of bioorthogonal chemistry has been successful in overcoming some of 
these challenges, but it often requires lengthy syntheses to incorporate unnatural amino 
acids. Meanwhile, the use of native protein functionality is often limited to the N- or C-termini 
or results in the unselective labelling nucleophilic residues such as cysteine or lysine. For 
these reasons there is great interest in expanding the toolbox of methods that permit the 
careful elaboration of protein architectures. 
 
In their latest work published in ACS Central Science, a team led by Francis, Doudna, and 
Fellman describes a method for coupling two biomolecules that bear tyrosine and 
cysteine residues, respectively. The enzyme tyrosinase is used to oxidize a solvent-
exposed tyrosine residue to an ortho-quinone functional group. This group subsequently 
reacts with the thiol-bearing component leading to the formation of a new covalent bond 
between the two substrates (Figure 1). This builds upon the team's previous experience in 
utilizing quinone functionality, formed in situ, for reactions with other nucleophiles present on 
biomolecules such as proline residues and anilines.3,4 While most proteins typically 
contribute a cysteine or lysine residue as the nucleophilic component of a bioconjugation 
reaction, the formation of an electrophilic ortho-quinone represents an interesting 
umpolung approach with the potential to expand the protein bioconjugation chemical 
space. 
 
The exact nature of the linkage that forms between the thiol and ortho-quinone groups was 
precisely determined by nuclear magnetic resonance (NMR) spectroscopy using small 
molecules as analogs for the larger biomolecules that are featured in the report. In contrast 
to the team's previous work that involved using the nitrogen-based functional groups prolines 
and anilines for the introduction of fluorophores into antibodies, the substitution at the ortho-
quinone took place at the 5 position and resulted in a thio-substituted catechol as the final 
product. Crucially, it was found that this linkage was significantly more stable in human blood 
serum over seven days relative to the one generated by the commonly used thiol-maleimide 
coupling procedure. The tyrosine activation method permitted the synthesis of a number of 
protein-peptide and protein-protein conjugates featuring substrates such as the green 
fluorescent protein (GFP), an antibody fragment, and smaller organic functional groups such 
as biotin and rhodamine. 
 
The team next applied their method to the functionalization of the Cas9 protein which is 
commonly used for genome editing, but suffers from poor cellular uptake. The Cas9 protein 
used in the report bears two surface cysteines that were targeted for modification. Following 
functionalization of these two cysteines with cell-penetrating peptides using the new 
tyrosine activation method, the team observed a 20-fold increase in editing efficiency 
compared to a control (Figure 2). Although the strategy of using cell-penetrating peptides 
has been used previously to improve the cellular uptake of the Cas9 protein,5 an advantage 
of the present approach is the relatively simple synthesis of the modified Cas9 construct. 
The ability of the method to elaborate a readily available Cas9 protein with cell-penetrating 
peptides is remarkable and raises the question of whether this method is unique or if other 
bioconjugation methods that utilize thiols would be applicable for the preparation of such a 
conjugate.6–8 An additional feature of note was the ability to perform mono- or di-conjugation 
by simple stoichiometric control. Plausibly, this opens the door to the synthesis of 
trifunctional constructs by two subsequent tyrosine/thiol bioconjugation reactions, if two 
cysteine residues are present in the protein of interest. 
 
In some cases, products corresponding to double bioconjugation were observed where only 
a single addition would be expected. Tentatively assigned to the participation of the N-
termini in a coupling reaction, such observations warrant further study and detailed 
characterization. It is also thought that tyrosine oxidation to the corresponding ortho-quinone 
is the rate determining step, followed by fast addition of thiol. Further reactivity and kinetic 
studies on each of these steps using isolated quinones, in the absence of tyrosinase, could 
help untangle these mechanistic details and shed more light on this promising method as 
well as the new molecules that it brings into existence. 
 
The controlled formation of unsymmetrical protein–protein conjugates using traditional 
bioconjugation approaches that rely on electrophile-tagged reagents to modify a nucleophilic 
residue on a protein is challenging. The team has “reversed” this strategy and used the 
enzyme tyrosinase to form an electrophilic ortho-quinone at tyrosine. Further controlled 
derivatization of the ortho-quinone using a cysteine-containing protein, enabled the formation 
of homogenous protein–protein constructs. The efficient generation of electrophilic reactive 
sites on proteins6,7,8 will facilitate the ready formation of homogenous protein–protein 
conjugates for research and therapeutic purposes. 
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Fig 1. Protein-protein conjugate of the green fluorescent protein (GFP) and an antibody 
fragment (scFv). The linkage arises from the coupling of a tyrosine and cysteine residue, 
mediated by the tyrosinase enzyme. 
 
 
Fig. 2. Left: Improved cellular delivery of Cas9-2SV40 protein-peptide conjugate relative to 
an unmodified control, assayed by cell fluorescence. Reproduced with permission from ref 1. 
Copyright 2020 American Chemical Society. Right: Structure of the Cas9 protein (PDB entry: 
5F9R) annotated with two 2SV40 cell-penetrating peptides. 
